Figure 3From: Exome profiling of primary, metastatic and recurrent ovarian carcinomas in a BRCA1-positive patient Mutation frequencies by two different sequencing methods. The correlation of mutant allele frequencies from exome sequencing and Sanger sequencing on validated mutations in the primary tumor, the omental metastasis, and the recurrent tumor after chemotherapy (Spearman’s rank correlation= 0.78, p = 7.865e-15).Back to article page